Physician profile
Rashel Low
NPI 1407408412
$1,359.75
in general payments reported to CMS, 2019-2025
8 companies · $459 in 2025
The $459 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $46.87 · 2023: $255 · 2024: $600 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,312.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $350.61 | 2023-2025 | Qelbree, Qelbree |
| Corium, LLC | $305.77 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $254.42 | 2022-2024 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $209.11 | 2025 | Jornay Pm |
| Tris Pharma INC | $110.94 | 2022-2025 | Dyanavel Xr |
| Axsome Therapeutics, INC. | $77.76 | 2024 | Auvelity |
| Vertical Pharmaceuticals, LLC | $29.29 | 2024-2025 | Relexxii |
| Baxter Healthcare | $21.85 | 2025 | Hillrom - Vest System Model 105 Home Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rashel Low listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.